Company: NGVT
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001653477-25-000108
Chunk: 33

Company: Ingevity Corp
Filing Date: 2025-08-05
Form: 10-Q
Item: Part I, Item 1
Chunk 33
---
.4)0.1 (1.3)(0.2)(Gains) losses reclassified to net income0.1 0.8 0.3 1.5 Less: tax (provision) benefit— 0.2 0.1 0.4 Net (gains) losses reclassified to net income0.1 0.6 0.2 1.1 Other comprehensive income (loss), net of tax(1.3)0.7 (1.1)0.9 Ending balance$(0.6)$(0.7)$(0.6)$(0.7)Pension and other postretirement benefitsBeginning balance$2.5 $0.5 $2.5 $0.5 Other comprehensive income (loss), net of tax— — — — Ending balance$2.5 $0.5 $2.5 $0.5 Total AOCI ending balance at June 30$4.2 $(37.5)$4.2 $(37.5)Reclassifications of accumulated other comprehensive income (loss)Three Months Ended June 30,Six Months Ended June 30,In millions2025202420252024Derivative instrumentsCurrency exchange contracts (1)$(0.2)$— $(0.2)$— Natural gas contracts (1)0.1 (0.8)(0.1)(1.5)Total before tax(0.1)(0.8)(0.3)(1.5)(Provision) benefit for income taxes— 0.2 0.1 0.4 Amount included in net income (loss)$(0.1)$(0.6)$(0.2)$(1.1)_______________(1) Included within "Cost of sales" on the condensed consolidated statements of operations.Share RepurchasesOn July 25, 2022, our Board of Directors authorized the repurchase of up to $500.0 million of our common stock (the "2022 Authorization"), and rescinded the prior outstanding repurchase authorization with respect to the shares that remained unused under the prior authorization. Shares under the 2022 Authorization may be purchased through open market or privately negotiated transactions at the discretion of management based on its evaluation of market prevailing conditions and other 

18

INGEVITY CORPORATIONNotes to the Condensed Consolidated Financial